Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.

F.V. van Venrooij; M.A. van der Ree; M.L. Bots; R.P. Stolk; M.V. Huisman; J.D. Banga

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.

Translated title of the contribution: Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.

F.V. van Venrooij
, M.A. van der Ree
, M.L. Bots
, R.P. Stolk
, M.V. Huisman
, J.D. Banga

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	1211-1216
Number of pages	6
Journal	Diabetes Care
Volume	25
Publication status	Published - 2002

Cite this

@article{4cb4767ef5784da3a9f82292a2536a12,

title = "Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.",

author = "\{van Venrooij\}, F.V. and \{van der Ree\}, M.A. and M.L. Bots and R.P. Stolk and M.V. Huisman and J.D. Banga",

year = "2002",

language = "Undefined/Unknown",

volume = "25",

pages = "1211--1216",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

}

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial. / van Venrooij, F.V.; van der Ree, M.A.; Bots, M.L. et al.
In: Diabetes Care, Vol. 25, 2002, p. 1211-1216.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.

AU - van Venrooij, F.V.

AU - van der Ree, M.A.

AU - Bots, M.L.

AU - Stolk, R.P.

AU - Huisman, M.V.

AU - Banga, J.D.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0149-5992

VL - 25

SP - 1211

EP - 1216

JO - Diabetes Care

JF - Diabetes Care

ER -